Adenocarcinoma of the Appendix - 170 Studies Found Status Study Completed Study Name: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condition: Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Date: 2004-03-08 Interventions: Procedure: adjuvant therapy Drug: paclitax Completed Study Name: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Condition: Brenner Tumor Fallopian Tube Cancer Ovarian Carcinosarcoma Date: 2004-06-10 Interventions: Drug: carboplatin Given intrap Recruiting Study Name: TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors Condition: Adult Glioblastoma Endometrial Clear Cell Adenocarcinoma E Date: 2014-05-16 Interventions: Biological: Bevacizumab Given Withdrawn Study Name: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Condition: Fatigue Malignant Ovarian Mixed Epithelial Tumor Neuropath Date: 2011-12-14 Interventions: Dietary Supplement: Acetyl-L-Carnitine Hydrochloride Recruiting Study Name: Vaccine Therapy in Treating Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer Following Surgery and Chemotherapy Condition: Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Tumor Other: Laboratory Biomarker Analysis Active, not recruiting Study Name: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Condition: Cognitive Side Effects of Cancer Therapy Malignant Ovarian Epithelial Tumor Procedure: Cognitive Assessment Active, not recruiting Study Name: Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy Condition: Mucinous Adenocarcinoma of the Colon Muci Date: 2013-08-29 Interventions: Other: cytology specimen collection procedure Completed Study Name: Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer Condition: Mucinous Adenocarcinoma of the Colon Muci Date: 2000-04-06 Interventions: Drug: irinotecan hydrochloride Recruiting Study Name: Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver Condition: Liver Metastases Mucinous Adenocarcinoma of the Colon Date: 2014-04-08 Interventions: Combination Product: irinotecan-eluting beads Recruiting Study Name: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers Condition: Cervical Adenosarcoma Cervical Adenosquamous Carcinoma Cer Date: 2013-12-19 Interventions: Biological: Bevacizumab Given <<< Previous | Next >>>